Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Hideki Marushima"'
Autor:
Tomoyuki Miyazawa, Kei Morikawa, Kanji Otsubo, Hiroki Sakai, Hiroyuki Kimura, Motohiro Chosokabe, Naoki Furuya, Hideki Marushima, Koji Kojima, Masamichi Mineshita, Junki Koike, Hisashi Saji
Publikováno v:
Thoracic Cancer, Vol 13, Iss 1, Pp 24-30 (2022)
Abstract Background In this study we aimed to clarify the PD‐L1 positive expression in lung adenocarcinoma, including various adenocarcinoma subtypes paying particular attention to its component. Methods A total of 307 lung adenocarcinoma patients
Externí odkaz:
https://doaj.org/article/0c62e06d77ed4ffd8db83d1cc8157c77
Autor:
Kanji Otsubo, Hiroki Sakai, Hiroyuki Kimura, Tomoyuki Miyazawa, Hideki Marushima, Koji Kojima, Naoki Furuya, Masamichi Mineshita, Motohiro Chosokabe, Junki Koike, Hisashi Saji
Publikováno v:
Thoracic Cancer, Vol 12, Iss 23, Pp 3169-3176 (2021)
Abstract Background The current study aimed to evaluate the significance of clinicopathological factors, particularly the immunohistochemistry of programed cell death ligand‐1 (PD‐L1), in eight cases each of pulmonary sarcomatoid carcinoma (PSC)
Externí odkaz:
https://doaj.org/article/7c341e2b3c4344559912d9d7076e951e
Autor:
Naoki Furuya, Koji Kojima, Hideki Marushima, Kazutaka Kakinuma, Akihito Tsunoda, Eriko Koda, Hajime Tsuruoka, Kohei Nishida, Takeo Inoue, Hisashi Saji, Masamichi Mineshita
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3391-3395 (2020)
Immune checkpoint inhibitors (ICIs) are the key drugs used in patients with non‐small cell lung cancer (NSCLC). However, anti‐PD‐1 therapy might worsen chronic infection by reactivating the immune response to infectious diseases. Here, we descr
Externí odkaz:
https://doaj.org/article/d98249704797403fabf975368c541123
Autor:
Tomoyuki Miyazawa, Kanji Otsubo, Hiroki Sakai, Hiroyuki Kimura, Motohiro Chosokabe, Kei Morikawa, Naoki Furuya, Hideki Marushima, Koji Kojima, Masamichi Mineshita, Junki Koike, Hisashi Saji
Publikováno v:
Cancer Control, Vol 28 (2021)
Background This study aimed to determine the relationship of programmed death-ligand 1 (PD-L1) expression and standardized uptake values in fluorodeoxyglucose–positron emission tomography/computed tomography (FDG-PET/CT) with prognosis in non–sma
Externí odkaz:
https://doaj.org/article/4cdb86f31fde47548c80bcef8808e09e
Autor:
Hideki Marushima, Hiroki Sakai, Reimi Yoneyama, Hiroyuki Kimura, Tomoyuki Miyazawa, Motohiro Chosokabe, Masahiro Hoshikawa, Koji Kojima, Masayuki Takagi, Hisashi Saji
Publikováno v:
Case Reports in Pulmonology, Vol 2020 (2020)
Pulmonary hyalinizing granuloma is a very rare benign condition. This study describes a case involving pulmonary hyalinizing granuloma in a 76-year-old man who presented with a solitary pulmonary nodule, determined through chest radiography and compu
Externí odkaz:
https://doaj.org/article/ef42f63a5a9b4ef2bd0d3339a037fa81
Autor:
Toshihide Tanaka, Naoki Kato, Ken Aoki, Aya Nakamura, Mitsuyoshi Watanabe, Satoru Tochigi, Hideki Marushima, Tadashi Akiba, Yuzuru Hasegawa, Toshiaki Abe
Publikováno v:
Case Reports in Neurological Medicine, Vol 2012 (2012)
A 41-year-old woman complained of chest pain when coughing. Computed tomography and magnetic resonance imaging disclosed a homogenously enhanced tumor occupying the spinal canal at the Th7 level and extending into the right paravertebral space throug
Externí odkaz:
https://doaj.org/article/878dacc4d3aa4c519b5e016f9714b282
Autor:
Masataka Nakano, Toshihide Tanaka, Aya Nakamura, Mitsuyoshi Watanabe, Naoki Kato, Takao Arai, Yuzuru Hasegawa, Tadashi Akiba, Hideki Marushima, Yukiko Kanetsuna, Toshiaki Abe
Publikováno v:
Case Reports in Neurological Medicine, Vol 2012 (2012)
Pulmonary metastases of benign meningiomas are extremely rare. The case of a 34-year-old man with bilateral parasagittal meningioma who developed pulmonary metastases is described. The meningioma was an enormous hypervascular tumor with invasion of t
Externí odkaz:
https://doaj.org/article/68cf7e88ef9c4e10a6e83b84aa370875
Autor:
Koji Kojima, Hisashi Saji, Hideki Marushima, Takeo Inoue, Eriko Koda, Naoki Furuya, Masamichi Mineshita, Kazutaka Kakinuma, Akihito Tsunoda, Kohei Nishida, Hajime Tsuruoka
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 11, Iss 11, Pp 3391-3395 (2020)
Thoracic Cancer, Vol 11, Iss 11, Pp 3391-3395 (2020)
Immune checkpoint inhibitors (ICIs) are the key drugs used in patients with non‐small cell lung cancer (NSCLC). However, anti‐PD‐1 therapy might worsen chronic infection by reactivating the immune response to infectious diseases. Here, we descr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72ba8fae25e933c2493dee0a185a478
https://doi.org/10.1111/1759-7714.13662
https://doi.org/10.1111/1759-7714.13662
Publikováno v:
Haigan. 60:298-304
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42f811ac5a703761619a12ef1710051e
https://doi.org/10.2482/haigan.60.298
https://doi.org/10.2482/haigan.60.298
Autor:
Hideki Marushima, Hiroyuki Kimura, Haruhiko Nakamura, Hisashi Saji, Naoki Furuya, Hiroki Sakai, Kojima Koji, Tomoyuki Miyazawa
Publikováno v:
Anti-Cancer Drugs
The relatively low toxicity profile of nab-paclitaxel plus carboplatin and its feasibility as an adjuvant administration was reported previously. This study aimed to evaluate the survival efficacy for completely resected patients with stage IB, II, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::253068abb3245eea368c2673de29b147
https://doi.org/10.1097/cad.0000000000000857
https://doi.org/10.1097/cad.0000000000000857